(0.06%) 5 251.53 points
(0.01%) 39 766 points
(-0.13%) 16 379 points
(1.95%) $82.94
(1.51%) $1.744
(1.13%) $2 237.70
(0.70%) $24.93
(1.28%) $921.35
(0.29%) $0.926
(0.76%) $10.85
(0.10%) $0.792
(0.14%) $92.57
Live Chart Being Loaded With Signals
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology...
Stats | |
---|---|
Today's Volume | 287 160 |
Average Volume | 126 375 |
Market Cap | 1.86M |
EPS | $0 ( 2024-03-08 ) |
Next earnings date | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0300 |
ATR14 | $0.00200 (0.66%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-01 | Benjamin Laura | Buy | 0 | |
2023-08-01 | Vazzano Joseph Walter | Buy | 0 | |
2021-12-20 | Carchedi Steve | Sell | 70 477 | Stock Options |
2021-12-20 | Carchedi Steve | Sell | 156 025 | Stock Options |
2021-12-20 | Carchedi Steve | Sell | 252 555 | Stock Options |
INSIDER POWER |
---|
0.00 |
Last 5 transactions |
Buy: 0 | Sell: 505 299 |
Volume Correlation
Allarity Therapeutics, Correlation
10 Most Positive Correlations | |
---|---|
JBLU | 0.983 |
AKTS | 0.982 |
FGEN | 0.98 |
BIOL | 0.979 |
NVCR | 0.977 |
WOOF | 0.976 |
SNPX | 0.975 |
RIDE | 0.974 |
HCSG | 0.973 |
GSIT | 0.973 |
10 Most Negative Correlations | |
---|---|
MSDA | -0.984 |
BRIVU | -0.984 |
NVCN | -0.973 |
BRIV | -0.972 |
SGII | -0.971 |
VLAT | -0.969 |
TIOA | -0.966 |
IXAQ | -0.963 |
TIOAU | -0.962 |
ALOR | -0.961 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Allarity Therapeutics, Correlation - Currency/Commodity
Allarity Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-37 000.00 (0.00 %) |
EPS: | $-5.98 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-9 000.00 (0.00 %) |
EPS: | $-0.870 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-18 000.00 (0.00 %) |
EPS: | $-2.24 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-18 000.00 (0.00 %) |
EPS: | $-6.39 |
Financial Reports:
No articles found.
Allarity Therapeutics,
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators